Ticker Details
Guardant Health, Inc.
IPO Date:	October 1, 2018
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$21.15B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.99 | 3.13%
Avg Daily Range (30 D):	$5.19 | 3.41%
Avg Daily Range (90 D):	$4.22 | 3.56%

Institutional Daily Volume
Avg Daily Volume:	1.36M
Avg Daily Volume (30 D):	2.18M
Avg Daily Volume (90 D):	2.01M

Trade Size
Avg Trade Size (Sh.):	67
Avg Trade Size (Sh.) (30 D):	48
Avg Trade Size (Sh.) (90 D):	55

Institutional Trades
Total Institutional Trades:	9,391
Avg Institutional Trade:	$3.93M
Avg Institutional Trade (30 D):	$18.59M
Avg Institutional Trade (90 D):	$10.82M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$9.59M
Avg Closing Trade (30 D):	$90.43M
Avg Closing Trade (90 D):	$50.01M
Avg Closing Volume:	149.21K

News

Jul 22, 2026 @ 8:49 AM Global Cancer Biomarkers Market to Reach $37.8 Bil... Source: Researchandmarkets.Com

Jun 19, 2026 @ 9:39 AM Ovarian Cancer Diagnostics Market Size to Reach US... Source: Sns Insider

Jun 8, 2026 @ 9:25 AM Why Grail Could Be the Sleeper Stock Everyone's Ab... Source: Keith Speights

Jun 5, 2026 @ 8:42 AM AI-Powered Imaging Systems and Deep Learning Softw... Source: Researchandmarkets.Com

May 20, 2026 @ 4:07 PM Guardant Health Secures FDA Approval For Expanded ... Source: Vandana Singh

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.9	$-.85
Diluted EPS	$-.9	$-.85
Revenue	$334.98M	$301.67M
Gross Profit	$219.03M	$196.75M
Net Income / Loss	$-120.14M	$-112.08M
Operating Income / Loss	$-129.12M	$-121.35M
Cost of Revenue	$115.95M	$104.92M
Net Cash Flow	$66.3M	$612.02M
PE Ratio